Wenxin-Keli regulates the calcium/calmodulin-dependent protein kinase II signal transduction pathway and inhibits cardiac arrhythmia in rats with myocardial infarction

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Xing, Yanwei ^a   Gao, Yonghong ^b   Chen, Jianxin ^b   Zhu, Haiyan ^b   Wu, Aiming ^b   Yang, Qing ^c   Teng, Fei ^a   Zhang, Dong Mei ^b   Xing, Yanhui ^a   Gao, Kuo ^b   He, Qingyong ^a   Zhang, Zhenpeng ^a   Wang, Jie ^a   Shang, Hongcai ^d  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^b BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^c NINGXIA MEDICAL UNIVERSITY   (China)

^d TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM ION; CHINESE DRUG; THREONINE; UNCLASSIFIED DRUG; WENXIN KELI;

AMPLITUDE MODULATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CALCIUM TRANSPORT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME REGULATION; HEART ARRHYTHMIA; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CELL; HEART WEIGHT; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION; SURVIVAL RATE; WESTERN BLOTTING;

EID: 84879308107     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/464508     Document Type: Article

References (34)

1. Rosamond W., Flegal K., Friday G., Furie K., Go A., Greenlund K., Haase N., Ho M., Howard V., Kissela B., Kittner S., Lloyd-Jones D., McDermott M., Meigs J., Moy C., Nichol G., O'Donnell C. J., Roger V., Rumsfeld J., Sorlie P., Steinberger J., Thom T., Wasserthiel-Smoller S., Hong Y., Heart disease and stroke statistics-2007 update: a report from the american heart association statistics committee and stroke statistics subcommittee. Circulation 2007 115 5 e69 e171 2-s2.0-33846857559 10.1161/CIRCULATIONAHA.106.179918
2. Hjalmarson A., Goldstein S., Fagerberg B., Wedel H., Waagstein F., Kjekshus J., Wikstrand J., Westergren G., Thimell M., El Allaf D., Vítovec J., Aldershvile J., Halinen M., Dietz R., Neuhaus K. L., Jánosi A., Thorgeirsson G., Dunselman P., Gullestad L., Kuch J., Herlitz J., Rickenbacher P., Ball S., Gottlieb S., Deedwania P., Vandenhoven G., Nováková I., Danker S., Lundström M., Meyer-Sabellek W., Balla I., Sveinsdottir M., Dorhout B., Hildebrandt A., Szczurko I., Larsson C., Bucher E., Scott E., Dwyer D., Julian D. G., DeMets D. L., Chatterjee K., Feyzi J., Lehto S., Kárpáti P., Motz W., Samuelsson O., Viersma J. W., Andersson B., Berthe C., Boutefeu J. M., Boxho G., Decroly P., Derbaudrenghien J. P., Pirlet J., Henry P., Heyndrickx G., Missault L., Nannan M., Timmermans P., Vachiery J. L., Van Mieghem W., Vandenbossche J. L., Dvorák K., Herold M., Hradec J., Kána A., Petr P., Rybka J., Smíd J., Svítil P., Toman J., Agner E., Amtorp O., Egstrup K., Eliasen P., Gotzsche C. O., Hildebrandt P., Johannesen A., Kaiser-Nielsen P., Nielsen H., Nielsen P. E., Pedersen F., Rokkedal Nielsen J., Skagen K., Honkanen T., Hussi E., Juvonen J., Jääskeläinen H., Rinne J., Salonen T., Andresen D., Berwing H., Bethge, Beythien, Bischoff, Bundschu, Daniel, Darius, Delius, Drude, Dingerkus, Dück, Eichler, Fach, Förster A., Girth, Goss, Hahn, Hambrecht, Hauf G. F., Heinemann, Hepp, Janka, Klocke, Konz, Krosse B., Kühlkamp, Lewek, Lüderitz B., Löbe, Maier, Melchior, Müller, Mäurer, Nast, Neuhaus, Obst, Odemar, von Olshausen K. E., Pomykaj, Schmailzl K. J. G., Schrader, Schröder, Schwimmbeck P. L., Sigmund M., Simon, Strasser, Thilo, Vöhringer, Völler H., Weibrodt, Wirtz, Wunderlich, Czuriga I., Hetey M., Katona A., Lengyel M., Nyárádi A., Rednik A., Sándori K., Szabó P., Tarján J., Tenczer J., Timár S., Vályi P., Veress G., Zámolyi K., Öze B., Thorgeirsson G., Thorgeirsson G., Bernink P. J. L. M., Bredero A. C., Breedveld R. W., Breuls P. N. W. M., Bucx J. J. J., Cornel J. H., De Milliano P. A. R., Dunselman P. H. J. M., Hamer B. J. B., Holwerda N. L., Hoogsteen J., Hoorntje J. C. A., Kragten J. A., Liem A. H., Linssen G. C. M., Michels H. R., Ramdat Misier A. R., Schaafsma H. J., Sijbring P., Taverne R. J. T., Van Kempen L. H. J., Van Stralen R., Van Veldhuisen P. J., Veerhoek M. J., Werter C. J. P. J., Wesdorp J. C. L., Willems A. R., Withagen A. J. A. M., Zwart P. A. G., Bjornerheim R., Dahle M., Dickstein K., Froland G. S., Gundersen T., Hofsoy K., Hole T. L., Johansen T., Mannsverk J., Nesje P., Omland T. M., Sjödin C., Smith P., Tjonndal H. A., Vikesdal O., Waage K., Adamus, Jaworska K., Kolodziej P., Kornacewicz-Jach Z., Krzemiñska-Pakula M., Piotrowski J. W., Piwowarska W., Stogowski A., Wodniecki J., Wrabec K., Ahlström P., Ekdahl S., Hemmingson L. O., Holmberg L., Lernfelt B., Nilsson B Widgren H., Ångman K., Erne P., Mohacsi P., Polikar R., Schläpfer H., Batin P., Berkin K. E., Callaghan T. S., Forfar J., Frenneaux M., Greenbaum R. A., Maltz M., Murdoch D., Reynolds G., Stephens J., Struthers A., Swan J., Tildesley G., Abbasi A., Alagona P., Alderman J., Alipour M., Anderson J. L., Ansari Z., Ashraf M., Beanblossom B. T., Bennett S., Benvenuti D., Berk M. R., Bhalla R., Bilazarian S. D., Browne K. F., MBuchter C., Carlson R., Carlson C. J., Danisa K., Dauber I., DeWood M. A., Dennish G., Denny D. M., DiBianco R., Diller P. M., Dunlap M., Dowd K., Edmiston A., El Shahawy M., Elkayam U., Farnham J., Fenster P., Friedman S., Heywood T., Galichia J. P., Geller M., Ghali J. K., Gheorghiade M., Giles T., Gillespe R., Goldberg G., Goldberg M. C., Goldscher D. A., Gooden G. P., Goodman M., Goodman L., Gorwit J., Gottlieb S. S., Gradman A., Grech D., Hack T., Hall J. H., Hattenhauer M. T., Higginbotham M. B., Hutchins S., Imburgia M., Iteld B. J., Jackson B., Jafri S., Jauch W., Jennison S., Kahn B. H., Kao W., Kaplan K., Karlsberg R., Kennedy H. L., Kennedy J. J., Kirkegaard L., Kraus D. H., LaBresh K., Lalonde L., Lesser M. F., Levites R., Levy M., Lewis R. K., Loh I. K., Madyoon H., Maislos F., Mann D., Maurice G. L., Nisar A., Old W., Pappas J. D., Phadke K., Promisloff S., Rashkow A. M., Reeves B., Rosen J. H., Rotman M., Saleem T., Savran S. V., Shah R., Shalev Y., Shanes J. G., O'Shaughnessy M., Silverman B., Steingart R. M., Swenson L., Syed K., Thadani U., Thorsen R. D., Tonkon M. J., Touchon R., Uhl G., Vaska K. J., Wagner S. G., Weaver C. J., Weiss R. J., Wickemeyer W. J., Willens H. J., Wilson J. R., Wright R., Yellen L., Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF). The Lancet 1999 353 9169 2001 2007 2-s2.0-0033549290 10.1016/S0140-6736(99)04440-2
3. Packer M., Bristow M. R., Cohn J. N., Colucci W. S., Fowler M. B., Gilbert E. M., Shusterman N. H., The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. The New England Journal of Medicine 1996 334 21 1349 1355 2-s2.0-0029937949 10.1056/NEJM199605233342101
4. Couchonnal L. F., Anderson M. E., The role of calmodulin kinase II in myocardial physiology and disease. Physiology 2008 23 3 151 159 2-s2.0-49049108214 10.1152/physiol.00043.2007
5. Waldo A. L., Camm A. J., DeRuyter H., Friedman P. L., MacNeil D. J., Pauls J. F., Pitt B., Pratt C. M., Schwartz P. J., Veltri E. P., Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The Lancet 1996 348 9019 7 12 2-s2.0-8944234858 10.1016/S0140-6736(96)02149-6
6. Echt D. S., Liebson P. R., Mitchell L. B., Peters R. W., Obias-Manno D., Barker A. H., Arensberg D., Baker A., Friedman L., Greene H. L., Huther M. L., Richardson D. W., Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The cardiac arrhythmia suppression trial. The New England Journal of Medicine 1991 324 12 781 788 2-s2.0-0026011647
7. Hund T. J., Saffitz J. E., Is CaMKII a therapeutic target for ventricular rate control? Heart Rhythm 2005 2 6 641 642 2-s2.0-19444385032 10.1016/j.hrthm.2005.04.009
8. 2+/calmodulin-dependent protein kinase in failing and nonfailing human hearts. Cardiovascular Research 1999 42 1 254 261 2-s2.0-0032897465 10.1016/S0008-6363(98)00296-X
9. 2+/calmodulin-dependent protein kinase in failing and nonfailing human myocardium. Circulation Research 1999 84 6 713 721 2-s2.0-0033515617
10. 2+/calmodulin-dependent protein kinase (CaMK) in excitation-contraction coupling in the heart. Cardiovascular Research 2007 73 4 631 640 2-s2.0-33846858884 10.1016/j.cardiores.2006.11.005
11. 2+ into arrhythmias. Journal of Cardiovascular Electrophysiology 2002 13 2 195 197 2-s2.0-0036195128
12. 2+ leak in heart failure. Circulation Research 2005 97 12 1314 1322 2-s2.0-31444444347 10.1161/01.RES.0000194329.41863.89
13. Curran J., Hinton M. J., Ríos E., Bers D. M., Shannon T. R., β -adrenergic enhancement of sarcoplasmic reticulum calcium leak in cardiac myocytes is mediated by calcium/calmodulin-dependent protein kinase. Circulation Research 2007 100 3 391 398 2-s2.0-33847058737 10.1161/01.RES. 0000258172.74570.e6
14. Venetucci L. A., Trafford A. W., O'Neill S. C., Eisner D. A., The sarcoplasmic reticulum and arrhythmogenic calcium release. Cardiovascular Research 2008 77 2 285 292 2-s2.0-38849121349 10.1093/cvr/cvm009
15. Marx S. O., Reiken S., Hisamatsu Y., Jayaraman T., Burkhoff D., Rosemblit N., Marks A. R., PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 2000 101 4 365 376 2-s2.0-0034640113
16. Blayney L. M., Lai F. A., Ryanodine receptor-mediated arrhythmias and sudden cardiac death. Pharmacology and Therapeutics 2009 123 2 151 177 2-s2.0-67349116018 10.1016/j.pharmthera.2009.03.006
17. Marks A. R., Ryanodine receptors, FKBP12, and heart failure. Frontiers in Bioscience 2002 7 d970 d977 2-s2.0-0036548733
18. Su N., Xu T., Tang Y., Zhou Z., Efficacy and safety of wenxin granules in the treatment of congestive heart failure: a systematic review. China Pharmacy 2010 21 7 4
19. Burashnikov A., Petroski A., Hu D., Barajas-Martinez H., Antzelevitch C., Atrial-selective inhibition of sodium-channel current by Wenxin Keli is effective in suppressing atrial fibrillation. Heart Rhythm 2012 9 1 125 131 10.1016/j.hrthm.2011.08.027
20. Sossalla S., Wagner S., Rasenack E. C. L., Ruff H., Weber S. L., Schöndube F. A., Tirilomis T., Tenderich G., Hasenfuss G., Belardinelli L., Maier L. S., Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts-role of late sodium current and intracellular ion accumulation. Journal of Molecular and Cellular Cardiology 2008 45 1 32 43 2-s2.0-45549105581 10.1016/j.yjmcc.2008.03.006
21. Xing Y., Chen J., Wang J., Gao Y., Niu W., Zhao M., Zhu H., Guo L., Lu P., Wang S., The effects of allitridi and amiodarone on the conduction system and reverse use-dependence in the isolated hearts of rats with myocardial infarction. Journal of Ethnopharmacology 2012 141 2 674 684 10.1016/j.jep.2011. 08.051
22. c isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure. Circulation Research 2003 92 8 912 919 2-s2.0-0038643573 10.1161/01.RES.0000069686.31472.C5
23. 2+ release. Circulation Research 2003 92 8 904 911 2-s2.0-0038643583 10.1161/01.RES.0000069685.20258.F1
24. Wu Y., Temple J., Zhang R., Dzhura I., Zhang W., Trimble R., Roden D. M., Passier R., Olson E. N., Colbran R. J., Anderson M. E., Calmodulin kinase II and arrhythmias in a mouse model of cardiac hypertrophy. Circulation 2002 106 10 1288 1293 2-s2.0-0037015257 10.1161/01.CIR.0000027583.73268.E7
25. Zhang R., Khoo M. S. C., Wu Y., Yang Y., Grueter C. E., Ni G., Price E. E., Thiel W., Guatimosim S., Song L. S., Madu E. C., Shah A. N., Vishnivetskaya T. A., Atkinson J. B., Gurevich V. V., Salama G., Lederer W. J., Colbran R. J., Anderson M. E., Calmodulin kinase II inhibition protects against structural heart disease. Nature Medicine 2005 11 4 409 417 2-s2.0-20244362095 10.1038/nm1215
26. 2+ release channels (ryanodine receptors). Science 1998 281 5378 818 821 2-s2.0-0032493913 10.1126/science.281.5378.818
27. Marx S. O., Gaburjakova J., Gaburjakova M., Henrikson C., Ondrias K., Marks A. R., Coupled gating between cardiac calcium release channels (ryanodine receptors). Circulation Research 2001 88 11 1151 1158 2-s2.0-0035827726
28. Okuda S., Yano M., Doi M., Oda T., Tokuhisa T., Kohno M., Kobayashi S., Yamamoto T., Ohkusa T., Matsuzaki M., Valsartan restores sarcoplasmic reticulum function with no appreciable effect on resting cardiac function in pacing-induced heart failure. Circulation 2004 109 7 911 919 2-s2.0-10744228679 10.1161/01.CIR.0000115526.92541.D2
29. Brittsan A. G., Kranias E. G., Phospholamban and cardiac contractile function. Journal of Molecular and Cellular Cardiology 2000 32 12 2131 2139 2-s2.0-0034509410 10.1006/jmcc.2000.1270
30. Na T., Dai D. Z., Tang X. Y., Dai Y., Upregulation of leptin pathway correlates with abnormal expression of SERCA2a, phospholamban and the endothelin pathway in heart failure and reversal by CPU86017. Naunyn-Schmiedeberg's Archives of Pharmacology 2007 375 1 39 49 2-s2.0-33847683001 10.1007/s00210-007-0134-1
31. Van Oort R. J., McCauley M. D., Dixit S. S., Pereira L., Yang Y., Respress J. L., Wang Q., De Almeida A. C., Skapura D. G., Anderson M. E., Bers D. M., Wehrens X. H. T., Ryanodine receptor phosphorylation by calcium/calmodulin-dependent protein kinase II promotes life-threatening ventricular arrhythmias in mice with heart failure. Circulation 2010 122 25 2669 2679 2-s2.0-78650701435 10.1161/CIRCULATIONAHA.110.982298
32. 2+ leak promotes atrial fibrillation in mice. Journal of Clinical Investigation 2009 119 7 1940 1951 2-s2.0-68849092129
33. ++/calmodulin-dependent protein kinase, decreases early afterdepolarizations in rabbit heart. Journal of Pharmacology and Experimental Therapeutics 1998 287 3 996 1006 2-s2.0-0032239112
34. 2+/calmodulin kinase signalling pathway in rat cardiac myocytes. The Journal of Physiology 2007 583 2 685 694 2-s2.0-34548322692 10.1113/jphysiol.2007.133066